| P50 | author | Deborah L. Galson | Q51170712 |
| P2093 | author name string | Dan Zhou | |
| | Silvia Marino | |
| | Xiang-Qun Xie | |
| | G David Roodman | |
| | Judith L Anderson | |
| | Quanhong Sun | |
| | Rebecca Silbermann | |
| | Juraj Adamik | |
| P2860 | cites work | The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation | Q22009927 |
| | Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1 | Q24294874 |
| | The LIM protein Ajuba influences interleukin-1-induced NF-kappaB activation by affecting the assembly and activity of the protein kinase Czeta/p62/TRAF6 signaling complex | Q24301337 |
| | Ajuba functions as a histone deacetylase-dependent co-repressor for autoregulation of the growth factor-independent-1 transcription factor | Q24314685 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | Regulation of gene expression in osteoblasts | Q27691363 |
| | Cancer statistics, 2014 | Q27861018 |
| | Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling | Q28082335 |
| | Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study | Q33942495 |
| | Expression of the transcriptional repressor Gfi-1 is regulated by C/EBP{alpha} and is involved in its proliferation and colony formation-inhibitory effects in p210BCR/ABL-expressing cells | Q34203955 |
| | Osteoblast inhibition by chemokine cytokine ligand3 in myeloma-induced bone disease | Q34720969 |
| | Distinct mechanisms for induction and tolerance regulate the immediate early genes encoding interleukin 1β and tumor necrosis factor α. | Q34926054 |
| | EZH2 or HDAC1 Inhibition Reverses Multiple Myeloma-Induced Epigenetic Suppression of Osteoblast Differentiation. | Q51170659 |
| | Small interfering RNA silencing of interleukin-6 in mesenchymal stromal cells inhibits multiple myeloma cell growth. | Q53256917 |
| | Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption | Q67602665 |
| | Fracture healing in metastatic bone disease | Q71823132 |
| | Ascorbic Acid-Dependent Activation of the Osteocalcin Promoter in MC3T3-E1 Preosteoblasts: Requirement for Collagen Matrix Synthesis and the Presence of an Intact OSE2 Sequence | Q73486339 |
| | Specific regulation of cytokine-dependent p38 MAP kinase activation by p62/SQSTM1 | Q80763828 |
| | Pathologic fractures correlate with reduced survival in patients with malignant bone disease | Q80974012 |
| | Regulation of osteoblast differentiation by Runx2 | Q84966232 |
| | Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease | Q35631319 |
| | Pathogenesis of myeloma bone disease | Q35683616 |
| | Paget disease of bone | Q36029217 |
| | A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells | Q36111590 |
| | Blocking the ZZ domain of sequestosome1/p62 suppresses myeloma growth and osteoclast formation in vitro and induces dramatic bone formation in myeloma-bearing bones in vivo. | Q36540462 |
| | Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition. | Q36569101 |
| | Snail/Gfi-1 (SNAG) family zinc finger proteins in transcription regulation, chromatin dynamics, cell signaling, development, and disease | Q36579298 |
| | Signaling and transcriptional regulation in osteoblast commitment and differentiation | Q36606452 |
| | Signal integration and diversification through the p62 scaffold protein | Q36686435 |
| | Mechanisms of multiple myeloma bone disease | Q37056408 |
| | RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism | Q37108966 |
| | Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation | Q37201872 |
| | Sequestosome-1/p62 is the key intracellular target of innate defense regulator peptide | Q37479210 |
| | Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma. | Q37584754 |
| | Gfi1 and Gfi1b: key regulators of hematopoiesis | Q37791430 |
| | The diagnosis and management of patients with idiopathic osteolysis | Q37945260 |
| | Multiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effects | Q37953844 |
| | The adaptor protein p62/SQSTM1 in osteoclast signaling pathways | Q37973113 |
| | Management of bone disease in multiple myeloma | Q38179039 |
| | Myeloma cells suppress osteoblasts through sclerostin secretion | Q38323256 |
| | KLF4-SQSTM1/p62-associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models | Q38860336 |
| | Gfi1 expression is controlled by five distinct regulatory regions spread over 100 kilobases, with Scl/Tal1, Gata2, PU.1, Erg, Meis1, and Runx1 acting as upstream regulators in early hematopoietic cells. | Q39697722 |
| | Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma | Q40009759 |
| | Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity. | Q40858675 |
| | Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential | Q42472805 |
| | AMPK promotes osteogenesis and inhibits adipogenesis through AMPK-Gfi1-OPN axis | Q42809876 |
| | Cancer and the microenvironment: myeloma-osteoclast interactions as a model | Q44802876 |
| | Improvement of photoaffinity SPR imaging platform and determination of the binding site of p62/SQSTM1 to p38 MAP kinase | Q44879054 |
| | GFI1 proteins orchestrate the emergence of haematopoietic stem cells through recruitment of LSD1. | Q48096449 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 344 | |
| P577 | publication date | 2018-06-29 | |
| P1433 | published in | Frontiers in Endocrinology | Q27723680 |
| P1476 | title | XRK3F2 Inhibition of p62-ZZ Domain Signaling Rescues Myeloma-Induced GFI1-Driven Epigenetic Repression of the Runx2 Gene in Pre-osteoblasts to Overcome Differentiation Suppression. | |
| P478 | volume | 9 | |